S&P 500
$5,844.61
-1.6%
-$95.85
DJI
41,860.44
-1.9%
-816.80
NASDAQ
$18,872.64
-1.4%
-$270.07
Bitcoin
110,469.00
+3.8%
+4,055.23
AAPL
$202.42
-2.1%
-$4.44
AMZN
$201.35
-1.3%
-$2.72
GOOG
$170.25
+3.0%
+$4.93
META
$635.69
-0.2%
-$1.41
MSFT
$453.22
-1.1%
-$4.95
NVDA
$131.94
-1.8%
-$2.44
TSLA
$334.80
-2.6%
-$9.02
Iterum Therapeutics Plc (NASDAQ: ITRM)
$0.90
(-5.8%)
-$0.05
Price as of May 21, 2025, 3:15 p.m. ET
Iterum Therapeutics Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Iterum Therapeutics Plc Company Info
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
News & Analysis
Featured Article
Why Iterum Therapeutics Stock Is Crashing Today
The company received disappointing news from the FDA.
Keith Speights | Jul 2, 2021
Featured Article
Why Iterum Therapeutics Stock Soared Today
The FDA gave the company some good news.
Keith Speights | May 28, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.